NIH-funded research R01 grant

Creating a model to study heart and liver function and disease

Official title: Microfluidic organoid model of cardio-hepatic physiology and disease

Funded at Icahn School of Medicine at Mount Sinai · NIH-11054684 · Data updated 2026-11-12

This study is working on a new way to create tiny models of the heart and liver that act like real human organs, which will help researchers better understand heart diseases and improve testing methods without needing to use animals.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startMarch 15, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$495,329
NIH project number5R01HL173456-02
Project IDNIH-11054684 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with cardiovascular diseases or conditions affecting liver function.

Less likely to help

Patients with stable cardiovascular and liver health may not receive direct benefits from this research.

What this research studies

This research focuses on developing a microfluidic organoid model that mimics the physiological functions of the heart and liver. By using advanced techniques, researchers aim to create a system that can accurately replicate human organ behavior, which is crucial for understanding cardiovascular diseases. The project will compare traditional cardiac models with new tube-shaped organoids to assess their functionality and organization. This innovative approach seeks to improve the reliability of preclinical testing and reduce the reliance on animal models.

Why it matters

Potential benefit: If successful, this research could lead to more accurate models for studying heart and liver diseases, ultimately improving treatment options for patients.

How similar studies have gone: Other research has shown promise in using organ-on-chip technologies, indicating potential success for this novel approach.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Sachs, David — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Sachs, David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.